Free Trial

KDA Group (CVE:KDA) Trading Up 26.3% - Should You Buy?

KDA Group logo with Medical background

Shares of KDA Group Inc. (CVE:KDA - Get Free Report) traded up 26.3% on Wednesday . The stock traded as high as C$0.36 and last traded at C$0.36. 557,858 shares traded hands during mid-day trading, an increase of 511% from the average session volume of 91,344 shares. The stock had previously closed at C$0.29.

KDA Group Stock Performance

The company has a market capitalization of C$63.14 million, a PE ratio of -7.50 and a beta of 1.24. The company has a 50 day moving average of C$0.26 and a two-hundred day moving average of C$0.27. The company has a debt-to-equity ratio of 7.36, a current ratio of 2.10 and a quick ratio of 0.35.

KDA Group Company Profile

(Get Free Report)

KDA Group Inc, together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, pharmacy re-engineering services, and pharmaceutical training services.

Further Reading

Should You Invest $1,000 in KDA Group Right Now?

Before you consider KDA Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KDA Group wasn't on the list.

While KDA Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines